Introduction
Trisomy 21 Down syndrome (T21DS) is the most common aneuploidy at birth and the most common genetic cause of mental retardation. It results from the gene expression of an extra chromosome 21, which occurs due to failure of normal chromosomal segregation during meiosis. [1] Eighty percent of these are lost during pregnancy [2] with the birth frequency of 1: 700-1: 1000. [3, 4] In addition to the maternal age which is an important risk factor, identification of the mechanistic basis for T21 requires an understanding of the cellular-molecular events and other biochemical pathways that could promote maternal meiotic nondisjunction. [3] DNA hypomethylation, abnormal gene expression, and abnormal chromosomal segregation occur as a consequence of folate deficiency. [4] The prime function of folate (Vit B 11 ) is to provide one-carbon moieties for the synthesis of three of the four bases of DNA, i.e., guanine, adenine, thymine as well as for the synthesis of methionine and S-adenosyl methionine (SAM) for essential methylation reactions including DNA methylation. Folate deficiency (RBC folate level <160 ng/ml) can be best diagnosed by determination of the RBC folate level. [5] The The association of the C677T polymorphism of the MTHFR gene has been studied in Indian Gujrati mothers and East Indian mothers by Rai, et al. [6] and Seth, et al. [7] respectively. Both reported a significant correlation with homozygous TT genotype. However, its simultaneous correlation with the biochemical parameters in the Indian subcontinent has not been investigated so far.
The practice implications of these findings may answer the intriguing question as to whether folic acid supplementation in women around conception can be effective in reducing risk of Down's syndrome.
Material and Methods
This case-control study was conducted in Department 
Results
We found a low value of serum folate (<3 ng/ml) in 34.62% in cases vs. 11.54% in controls, which was folate, but the combination of both serum and RBC folate was significant (P value 0.020). The emerging data also highlighted the impoverished nutritional status of both the case and control mothers which may have had a significant impact on other fetal growth parameters.
Discussion
Down syndrome is the first clinically defined genetic disorder shown to be chromosomal in origin. It is characterized by multiple somatic anomalies and cognitive impairment. Although common cellular and molecular mechanism involved in this meiotic nondisjunction remain unknown, folic acid and polymorphism on gene coding for enzymes involved in its metabolism are thought to influence meiotic disjunction. [8, 9] As shown below [ Table 1] the frequency of homozygous normal (C/C) in our study was 84.61% in comparison to 26.3% in study by James, et al. [3] The heterozygous mutant (C/T) in our study was 15.38% in comparison to 59.6% in the above study. We did not find any homozygous mutant either in cases or in controls. This is not surprising given the low incidence of T allele in Asians as well as a small sample size.
The low T allele frequency was also observed in south India in a study by Cyrus, et al., [12] the minor allele frequencies (T allele) in case mothers and fathers were 4.17% and 6.94% respectively. The cause may be no preferential transmission of T allele and ethnicity genetic prevalence. The frequency of the C/C genotype was significantly higher in the mothers of children with Down syndrome than in control mothers. The overall mutant allele frequency was not significantly higher in mothers of children with Down syndrome than in control mothers.
We found combined mutant allele frequency in Down, 15 .38%, and in control mothers 5.88 % in our study. In an Indian study by Sheth, et al. [7] the mutant alleles were 53.84% and 28.5% in cases and controls respectively.
In some Indian studies [ Table 2 ] combined mutants
were not higher in Down syndrome mothers compared to controls. In our study though combined mutants were higher in Down syndrome mothers than controls in absolute number, the relationship was not statistically significant. We did not get any homozygous TT genotype in our case and control groups. Low frequency of the T allele and its heterozygous distribution among Indians has been well documented by Franco, et al. [14] Singh, et al. did not get a single homozygous in the control group where this polymorphism was evaluated for male infertility. [15] A study done in AIIMS by Kohli, et al. (2004) showed 28.16% mutant allele against 15.38% in our case. They did not find any homozygous TT genotype in case mothers.
Analyzing the data of MTHFR polymorphism in relation to the age group of below and above 30 we found no significant association in the age group less than 30 years (P = 0.445) and in more than 30 years (0.220) [ Table 3 ]. Although we did not find association with polymorphism and Down syndrome, there might also be a possible independent effect of maternal MTHFR polymorphism on meiotic nondisjunction by an indirect effect on oocyte DNA. The reduced MTHFR enzyme activity results in increased level of homocysteine, reducing the resynthesis of methionine and producing DNA hypomethylation.
[3] 
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James et al. [3] 26.3 59.6 14.0 73.6 48.0 44.0 8.0 52.0 Hobbs et al. [4] 31.0 54.0 14.0 68.0 48.0 42.0 10.0 52.0 Stupia et al. [10] 31.0 50.7 18.3 69.0 24.1 55.4 20.5 75.9 O'Leary et al. [11] 44.0 51. We studied serum levels of folate, RBC folate, vitamin B12, homocysteine, and MTHFR polymorphism in mothers of Down syndrome versus control mothers. [16] [17] [18] We studied RBC folate in addition as it is a preferred marker to assess long-term folate status. Plasma folate is indicative about recent folate status. In our study, even though the isolated analysis of polymorphism did not show an association with maternal risk for Down syndrome, we observed the higher median number of polymorphic alleles in Down syndrome mothers compared to controls. The result of this initial study indicates that folate metabolism is abnormal in mothers of children with Down syndrome and this may be explained, in part, by the genetic susceptibility due to polymorphism in the MTHFR gene. [15] Published literature had shown that folate and vitamin B12 may not be the only cause of nondisjunction and meiotic error in Down syndrome. It has also been observed that low thiols is indicative of low protein intake can be a cause of hyperhomocysteinemia. Hyperhomocysteinemia, whether caused by a genetic mutation or diet, alters the abundance of several liver proteins involved in homocysteine/ methionine metabolism, and antioxidant defense. [16] We also studied the association of serum folate, vitamin B12, and homocysteine levels with C677T polymorphism of MTHFR gene. We found significant association of serum folate with C677T polymorphism (P value 0.005). There were no significant association of RBC folate but was depicting an emerging trend and vitamin B12 and homocysteine with C677T polymorphism (P values 0.118, 0.16, and 0.124 respectively).
Nevertheless vitamin B12 status is almost normal in the study and control groups. In the combined risk factor study we found significant correlation in combining serum and RBC folate (OR = 3.41, 95% C1-1.21-9.59, P value = 0.02), but we did not find any significant correlation in other combinations as the number was very small, and hence statistical analysis could not be [ Table 4 ], carried out. Nevertheless, we found statistical significant low serum and RBC folate in > 30yr age group mothers [ Table 5 ]. This was a limitation in our study. The serum vitamin B12 level in controls was normal and in cases there were four abnormal values only reflected in our study, so low folate may have had a direct impact on high homocysteine leading to meiotic error, the most common cause of Down syndrome.
Conclusion
Our study also revealed higher amount of plasma homocysteine in Down syndrome mothers compared to control mothers though it could not satisfy significant statistical association with MTHFR gene polymorphism. Our study failed to statistically confirm the association of low RBC folate with occurrence of Down syndrome, although it gave a trend as RBC folate is a more reliable marker. However the combined factors of low serum and RBC folate are significantly associated. Larger studies in the Indian subcontinent are therefore required with adequate power to assess the results of our study. The increase of homocysteine can be lowered or prevented by folic acid; thus the metabolic imbalance with genetic mutation can be largely prevented. Our study though initially suggesting the importance of interaction between gene and folate (environment) failed to confirm the association. This has also been suggested by another North Indian cohort study done by Kohli et al. ; [13] they however did not analyze vitamin B12 or RBC folate in relationship to the polymorphism.
Currently, we may suggest that a much larger multicentric study needs to look into the geo-ethnic 
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